Patent · US Active

Methods of treatment using human anti-IL-23 antibodies

US8221760B2 · kind B2 · utility

19Cited by
18References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2011
Grant dateJul 17, 2012
Priority date
Expiry dateJun 30, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.